[1] |
杨姣, 陈松. 吉非替尼联合吉西他滨和顺铂治疗晚期非小细胞肺癌的临床疗效[J]. 实用临床医药杂志, 2020, 24(19):63-66.
|
[2] |
GE C, PETERS S, OLSSON A, et al. Diesel engine exhaust exposure,smoking,and lung cancer subtype risks. A pooled exposure-response analysis of 14 case-control studies[J]. Am J Respir Crit Care Med, 2020, 202(3):402-411.
DOI
URL
|
[3] |
WANG B, WANG D Q, LIN M S, et al. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy[J]. BMC Cancer, 2020, 20(1):1112.
DOI
PMID
|
[4] |
WANG H, CHEN X, YANG B, et al. MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1/Wnt/β-catenin signaling pathway[J]. Cancer Cell Int, 2020, 20:491.
DOI
PMID
|
[5] |
郭舜, 石磊, 张松, 等. 黄芩素通过调控糖酵解及谷氨酰胺代谢抑制肝癌细胞能量代谢[J]. 中国药师, 2021, 24(12):2154-2159.
|
[6] |
HASSANEIN M, QIAN J, HOEKSEMA M D, et al. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer[J]. Int J Cancer, 2015, 137(7):1587-1597.
DOI
PMID
|
[7] |
LIU Y, WANG S, PAN S, et al. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling[J]. J Clin Lab Anal, 2022, 36(1):e24116.
DOI
URL
|
[8] |
叶静静, 徐文琴, 陈天兵. 肝细胞癌中促癌miRNA调控网络分析与验证[J]. 南方医科大学学报, 2022, 42(1):45-54.
DOI
|
[9] |
王琳瑶, 薛逢来, 史晓舜, 等. miRNA在肺癌中的作用机制及潜在临床意义[J]. 中华胸部外科电子杂志, 2021, 8(1):40-50.
|
[10] |
马跃, 高英静, 何浪. 乳腺癌差异表达miRNA在预后中的意义[J]. 医学研究杂志, 2018, 47(1):39-44.
|
[11] |
赵文钺, 刘璐, 王黎明, 等. 雌激素调控miRNA在非小细胞肺癌发生发展及预后的分子机制[J]. 解剖科学进展, 2020, 26(3):354-356.
|
[12] |
王蓉, 邢连翔, 黄克亮, 等. miR-374靶向下调TRIM35表达可促进乳腺癌细胞增殖和侵袭[J]. 检验医学, 2023, 38(9):812-817.
DOI
|
[13] |
潘信, 吕颖, 李阳, 等. miR-24-3p靶向CHD5影响甲状腺癌细胞迁移能力、侵袭能力和放射敏感性[J]. 检验医学, 2023, 38(7):640-646.
DOI
URL
|
[14] |
周湘华, 赵其辉, 张志伟. miR-924靶向TGM2抑制胃癌MGC803细胞增殖[J]. 中南医学科学杂志, 2020, 48(3):244-249.
|
[15] |
李俊川, 杨烈, 杨柳, 等. 微小RNA-924靶向调控Cdc42表达及对肝癌细胞迁移和侵袭的影响[J]. 临床肿瘤学杂志, 2019, 24(3):201-205.
|
[16] |
陆健, 龚镭, 王小云, 等. 氨基酸转运载体SLC1A5在胃癌组织中的表达及其临床病理学意义[J]. 现代生物医学进展, 2019, 19(20):3880-3885.
|
[17] |
SCALISE M, MAZZA T, PAPPACODA G, et al. The human SLC1A5 neutral amino acid transporter catalyzes a pH-dependent glutamate/glutamine antiport,as well[J]. Front Cell Dev Biol, 2020, 8:603.
DOI
URL
|
[18] |
白长森. 乏氧条件下肿瘤细胞谷氨酰胺碳氮协同代谢的机制研究[D]. 天津: 天津医科大学, 2019.
|
[19] |
SUDO H, TSUJIA B, SUGYO A, et al. Direct comparison of 2-amino[3-11C]isobutyric acid and 2-amino[11C]methyl-isobutyric acid uptake in eight lung cancer xenograft models[J]. Int J Oncol, 2018, 53(6):2737-2744.
|